The University of Siena PhD Course in
Genetics, Oncology and Clinical Medicine
Genetics, Oncology and Clinical Medicine
PhD Graduate

PhD Program years: 2008 - 2012
PUBLICATIONS DURING THE PHD PROGRAM
1) CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells.
Rom S, Rom I, Passiatore G, Pacifici M, Radhakrishnan S, Del Valle L, Piña-Oviedo S, Khalili K, Eletto D, Peruzzi F.
FASEB J. 2010 Jul;24(7):2292-300.
2) Induction of Id-1 by FGF-2 involves activity of EGR-1 and sensitizes neuroblastoma cells to cell death.
Passiatore G, Gentilella A, Rom S, Pacifici M, Bergonzini V, Peruzzi F.
J Cell Physiol. 2010 Nov 10.
3) HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.
Rom S, Pacifici M, Passiatore G, Aprea S, Waligorska A, Del Valle L, Peruzzi F.
Biochim Biophys Acta. 2011 Oct;1813(10):1836-44. Epub 2011 Jul 1.
ABSTRACTS OF CONFERENCE DURING THE PHD PROGRAM
2) HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction (LCRC Annual Scientific Retreat 2011
New Orleans, LA, USA)
ACTIVITY DURING THE PHD PROGRAM
TRAINING PERIOD ABROAD
- Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania
2010: twelve months